Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Steve will be monitoring the Rapid Fires: AI/ML in Bioanalysis session on Monday, Nov. 10, 2025 at 3PM CT at AAPS PharmSci ...

The company aims to bring its technology — a lab-free detection method for cancers, viruses, and bacteria — to market in 2026 ...

The review also calls for embedding diagnostics within the One Health framework, which integrates human, animal, and ...

New England Biolabs (NEB®) today announces the release of the NEBNext Flu A Integrated Indexing Primer Module (NEB #E3436), ...

Since 1901, the Nobel Prize has honored ideas that changed the way we live. From discoveries that made headlines to ...

Diagnostics, Inc. (NASDAQ: CODX) ("Co-Diagnostics," "Co-Dx," or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, ...

Visby Medical’s new at-home PCR test for women delivers results in 30 minutes—and can arrive the same day via GoPuff or ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

At K 2025, Hans Weber Maschinenfabrik GmbH showcased new developments designed to improve the durability, efficiency and ...

Certain serious fungal infections occur in regions of the United States with specific environments and are often tied to soil ...